Viropharma (VPHM): Upgraded to Outperform at Oppenheimer
Tweet Send to a Friend
From Notable Calls
Oppenheimer is upgrading Viropharma (NASDAQ: VPHM) to Outperform from Sector Perform with a $13 target.
According to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer is upgrading Viropharma (NASDAQ: VPHM) to Outperform from Sector Perform with a $13 target.
According to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
